Microlight3D and Eden Tech are collaborating to advance the development of microfluidic equipment for healthcare researchers ...
D Investment Partners Pte. Ltd., the asset management company of 3D OPPORTUNITY MASTER FUND (collectively referred to as "3D," "we" or "our"), today released a supplemental presentation in response to ...
Net revenue and EPS results HP Inc. and its subsidiaries (“HP”) announced fiscal 2025 first quarter net revenue of $13.5 billion, up 2.4% (up 3.3% in constant currency) from the prior-year period.
Howard Master and Alberto Orozco discuss how shifts in U.S. foreign policy, particularly under the new administration, are ...
SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today presented the first preclinical data on SOT109, a novel antibody-drug conjugate (ADC) targeting cadherin-17 (CDH17).
Pro Medicus is in a strong financial position. As of June 2024, it had AUD 155 million in net cash, and we forecast the company to continue holding net cash over our explicit 10-year forecast period.
Intangible AI, now backed by $4 million in seed funding, offers an AI-powered creative tool that allows users to create 3D ...
However, this business model is not widespread and there are still many more assets that are partially developed, only to be abandoned. This leaves many drug prospects needing a champion to return ...
It was during a chat with CBS Mornings that Demi Moore opened up about the raw vulnerability required to bring some of the ...
Neue Theory, a mission-driven, female-founded wellness brand created by dietitian Abbey Sharp has included several gift boxes ...
The biotech’s main asset is bimagrumab, a monoclonal antibody that could potentially simultaneously help to build muscle and reduce fat. The drug candidate is already being tested in phase 2b ...
An explanation of ethics rules, preventive practices, and potential consequences related to attorney self-dealing, and how ...